HCW Biologics reports positive Phase 1 data for alopecia drug HCW9302

June 16, 2026 7:00 AM

HCW Biologics Inc. (NASDAQ: HCWB) announced preliminary positive results from the first two dose cohorts of its Phase 1 clinical ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found